Kodiak Sciences Inc. (KOD) financial statements and ratios from SEC XBRL: revenue $4.52M (TTM), net margin -5091.1%, revenue growth -59.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.52M |
| Net Margin | -5091.1% |
| Revenue Growth (YoY) | -59.5% |
| EPS Growth (YoY) | 29.0% |
| FCF Growth (YoY) | 16.0% |
| Price / Book | 40.91 |
| Price / Sales | 458.29 |
| FCF Yield | -10.7% |
| Altman Z-Score | -0.22 (distress) |
| Sector P/E (Healthcare) | 21.6 |
KOD overview · KOD earnings · KOD KPIs · KOD investor relations · KOD ownership · KOD peers · KOD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.